74
CR Hematology

CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Embed Size (px)

Citation preview

Page 1: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

CR Hematology

Page 2: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

RBCs DisordersAnemias

&Others

WBCs DisordersBenign & Malignant

Hemostatic Disorders

Hematological Disorders

Page 3: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Introduction

• Blood consists of 55% plasma and 45% formed elements.

• Formed elements include erythrocytes, leukocytes, and thrombocytes.

Page 4: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Erythrocytes• Normal range 4.0-5.0

million per mm3 in adults.

• Biconcave shape.• Diameter 7 microns.• Cells for transport

of O2 and CO2.

• Life span 120 days.

Page 5: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Leukocytes

• Normal range 4 - 11 thousand per mm3

in adults.• Five types.• Size 8-20 microns.• Involved in fighting

infection, combating allergic reactions, and immune responses.

Page 6: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Thrombocytes

• Smallest cells in the blood.

• Normal range 150,000-400,000.

• Active role in coagulation and hemostasis.

Page 7: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

RBC Disorders

Page 8: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Anemia• Defined by measurement of hemoglobin

concentration.• Manifestations (symptoms) are related to

duration and severity of anemia– Body has physiologic responses to chronic

anemia such that many patients are asymptomatic until hg < 8 g/dl .

– Fatigue, pallor, dyspnea, dizziness and dyspnea on exertion

Page 9: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Signs

• Pallor of mucous membranes (conjunctiva, tongue, palm of the hands).

• Nails are delicate and break easily.• Hair is thin.• Rough skin.

Page 10: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Classifications of Anemias

Microcytic, HypochromicMicrocytosis – small cells (MCV <80)

– Iron deficiency– Sideroblastic– Anemia of chronic disease– Lead poisoning– Thalassemia trait

Page 11: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Microcytic, Hypochromic

• Many RBCs smaller than

nucleus of normal

lymphocytes, increased central pallor.

Page 12: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Classifications of AnemiasNormochromic

– Hereditary Spherocytosis– PNH– G6PD deficiency– Aplastic anemia– Acute blood loss

Page 13: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Classifications of Anemias

Macrocytic– Vitamin B12 deficiency– Folate deficiency– Liver disease– Drugs– MPD

Page 14: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Macrocytic RBCs

• Most RBCs larger than nucleus of normal

lymphocytes.

• increased MCV.

Page 15: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Macrocytic Anemia

Macrocytosis – large cells (MCV >100)

Check vitamin B12, RBC folate (why?), fasting homocysteine, and methylmalonic acid (MMA)

*HC and MMA are elevated in subclinical B12 and folate deficiency

Page 16: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

IRON DEFICIENCY ANAEMIA.

Iron deficiency is the most common cause of anemia in every common country of the world, and it is the most important cause of microcytic hypochromic anaemia.

Page 17: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Nutritional and metabolic aspects of the iron:

Iron in the body is about 2.5-3 g. Iron in the Haemoglobin of the RBC

represents a greatest percent of body constitutes.

Iron presents in the body in two forms:

- Ferrittin. - Haemosiderin.

Page 18: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Causes of iron deficiency anaemia:

1. Chronic blood loss, especially gastrointestinal tract.

2. Increased demands, during pregnancy, infancy, growth, lactation and menstruated women.

3. Malabsorption especially in the cases of gastroectomy and peptic ulcer.

4. Poor diet.

Page 19: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Clinical features:1. When IDA is developing, the RE stores

(hemosiderin and ferritin) become completely depleted before anemia occurs.

2. At an early stage, no clinical abnormalities.

3. Later, patient may develops general symptoms and signs of anemia.

4. Spoon or ridged nails in severe case of IDA.

5. Dysphagia.

Page 20: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Laboratory findings:•Red cell indices:

Low Hb conc.MCV, MCH, MCHC*

•Blood film:Hypochromic microcytic Picture.Occasional Target cells.Pencil shaped poikilocytes.Normal reticulocyte count.

•Bone marrow iron:Normal to hypercellular.RBC precursors are increased in number.Iron stain negative.

•Chemical testing on serum:Serum iron Decreased Transferrin/TIBC Normal to HighSerum ferritin Decreased (Very low)

Page 21: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

DD. Of microcytic anemia

Page 22: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Sideroblastic anemias

Page 23: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Characterized by

Increase in total body iron

Presence of ringed sideroblasts in bone marrow

Hypochromic anemia.

Page 24: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Classification

• Hereditary form• Acquired form (more common)• Idiopathic – Refractory anemia with ringed

sideroblasts(RARS)• secondery

Page 25: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Pathophysiology

• Disturbances of enzymes regulating heme synthesis• Ringed sideroblasts form when non-

ferritin iron accumulated in the mitochondria that circle the normoblast nucleus

Page 26: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Hereditary Sideroblastic Anemia

• Most common form is sex-linked and due to an abnormal aminolevulinate

synthetase enzyme (ALAS)• Decreased heme synthesis due to block in iron utilization perceived by body as

increased need for iron associated with increased iron absorption results in iron overload

Page 27: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Acquired Sideroblastic Anemia

Idiopathic RARS– acquired stem cell disorder Secondary• Lead poisoning (plumbism) Inhibits cellular enzymes involved in heme

synthesis• Malignancy

Page 28: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Laboratory findings in SA –Peripheral Blood

• Moderate to severe anemia• Target cells• Basophilic stippling • ↑Fe, N to ↓TIBC, ↑% saturation, ↑ ferritin

• Bone marrow: -Erythroid hyperplasia -Ringed sideroblasts in more than 15% of

normoblasts.**Lower number of ringed sideroblast in variety of

hematological disorders.

Page 29: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Macrocytic anemia

Page 30: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Macrocytic anemia

• Other causes include:– Drug toxicity– Hypothyroidism– Liver disease– Myelodysplasia– MPO

Page 31: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Megaloblastic macrocytosis

• The smear in a patient with macrocytic anemia is helpful in identification of megaloblastic changes – macrocytes and hypersegmented neutrophils (>5 lobes)

• DD: B12 deficiency, folate deficiency, drugs that cause abn.DNA synthesis or folate metabolism, liver disease and myelodysplastic syndromes

• Non-megaloblastic macrocytosis, on smear patients may have large target cells and acanthocytes.

Page 32: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Folate deficiency Found in: Fruits (e.g. citrus, melon, bananas),

leafy green vegetables. Causes include:

Malabsorption MedicationsMalignancy HemodialysisDiseases/conditions associated with rapid cell

turnover such as pregnancy, infancy,….

Page 33: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Vitamin B12 deficiency Found in : (meat, fish) The body stores large amounts of B12 therefore

decreased dietary intake rarely lead to deficiency Medications to decrease stomach acid can also

contribute to B12 deficiency (antacids) Vegetarians can also contribute to B12 deficiency In addition to causing anemia, B12 deficiency can lead

to a metabolic peripheral=neuropathy and gastrointestinal disorders.

Page 34: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Diagnosis

1. Blood cell count:

• macrocytic anemia ( MCV>100fl )• thrombocytopenia• leucopenia (granulocytopenia)• low reticulocyte count 2. Blood smear: • macrocytosis , anisocytosis.• hypersegmentation of granulocytes

Page 35: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Diagnosis

3. Laboratory features hyperbilirubinemia elevation of lactate dehrogenase (LDH) serum iron concentration- normal or increased 4. Bone marrow smear hypercellular erythroid cell changes (megaloblasts, an abnormally large

cell with nuclear- cytoplasmic asynchrony) myeloid cell changes (hypertsegmentation) megakaryocytes are decreased and show abnormal

morphology

Page 36: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Hemolytic AnemiaNormocytic

Normochromic

Page 37: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Hemolytic Anemia•Congenital

–Membrane defects•Hereditary spherocytosis•Hereditary elliptocytosis

–Enzyme defects•G6PD deficiency, PKD.…,

Page 38: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Hemolytic Anemia

• Acquired– Classified according to site of RBC destruction and/or whether

mediated by immune system:• Intravascular• Extravascular• Immune• Non-immune

– Causes: –• Transfusion of incompatible blood• Autoimmune

– Warm (IgG-mediated) ; most common– Cold (IgM-mediated)

• Prosthetic valves• TTP/HUS• DIC• Cancer• Drugs

Page 39: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Haematological findings in HS

• Anaemia is usual.[Increased mean corpuscular hemoglobin concentration (MCHC)]

• Reticulocytosis 5-20%• Microspherocytes are seen in the blood film.

(densely staining with smaller diameters than normal red cells).

Page 40: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Other investigations

• The classic finding is that the osmotic fragility is increased.

• Autohaemolysis is increased and corrected by glucose.

• Direct antiglobulin test is normal

Page 41: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

G6PD deficiency

• G6PD functions to reduce nicotinamide adenine dinucleotide phosphate (NADP) while oxidizing glucose-6-phosphate.

• NADPH is needed for the production of reduced glutathione (GSH) which is important to defend the red cells against oxidant stress.

Page 42: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Clinical features

• G6PD deficiency is usually asymptomatic.• Neonatal jaundice.• Acute haemolytic anaemia in response to

oxidant stress: drugs, fava beans or infections.

Page 43: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Laboratory diagnosis

• Between crises blood count is normal.• The enzyme deficiency is detected by

– One of a number of screening tests or– By direct enzyme assay on red cells.

• During the crisis, the blood film may show contracted and fragmented cells, bite, blister cells, ………

• Enzyme assay may give a false normal level in the phase of acute haemolysis.

Page 44: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

• The blood film shows irregularly contracted cells [deep red arrows]

and sometimes hemighosts [deep blue arrow] in which all the hemoglobin appears to have retracted to one side of the erythrocyte

Page 45: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Polycythemia / Erythrocytosis

• Abnormal elevation of hemoglobin– Rule out “relative” polcythemia caused by contraction of plasma volume,

e.g. dehydration– Primary

• Polycythemia Vera– RBC production independent of EPO

» EPO level is low / positive JAK-2 is diagnostic– Uncommon– May be associated with leukocytosis, thrombocytosis, splenomegaly– Hyperviscosity

» Headache, vertigo, visual changes, mental confusion– Risk of transformation into acute leukemia– Treatment??

– Secondary• RBC production in response to increased EPO production

– EPO level is usually high• Very common• Usual etiology is chronic hypoxia (COPD)**……………. (250-500 ml) to maintain hct 45-50% and treat underlying problem

Page 46: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Reticulocytes• Immature RBCs.• Contain residual

ribosomal RNA.• Reticulum stains

blue using a supravital stain (new methylene blue).

• Counted and expressed as % of total red cells.

Page 47: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Reticulocyte Count

Retic % = # retics per 100 RBCs

Corrected retic= % retics x pt. HCT

45

Page 48: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Haemoglobinopathies

Page 49: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

• A group of inherited disorders characterized by structural variations of the Hb molecule. They are Disorders of globin synthesis rather than heme synthesis.

• These may result from : 1. Synthesis of abnormal Hb2. Reduced rate of synthesis of NORMAL α or β

globin chains• Genetic defects of Hb are the most common

genetic disorders worldwide.

What are hemoglobinopathies?

Page 50: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

SICKLE CELL ANAEMIA

Page 51: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Sickle cell disease is a group of haemoglobin disorders, in which there is inherence globin abnormality, caused by substitution of valine for glutamic acid in position 6 in the ß chain.

Page 52: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

• Hb S is insoluble and forms crystals when exposed to low oxygen tension.

• Deoxygenated Hb polymerizes into long fibers which may block different areas of the microcirculation or large vessels causing infarcts of various organs.

Page 53: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Clinical features:- Chronic haemolysis, leads to jaundice and anemia.- Vaso-occlusion of blood vessels leads to pain.- Infarction and infections.

Page 54: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

1. Low Hb.2. Peripheral blood film shows, sickle cells,

target cells and howell-Jolly body appears.3. Positive Sickling test (screening test).4. Hb electrophoresis (confirmatory test) :

-Hb SS : 80 – 100% - no Hb A - Hb F : 5 – 15%

Page 55: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Howell-Jolly bodies

• These are basophilic nuclear remnants (clusters of DNA) in circulating erythrocytes.

• They are usually observed in hemolytic anemia, following splenectomy, and in cases of splenic atrophy.

Page 56: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

The Sickling Test

• This is a wet preparation.• 5 drops of reagent (Sodium dithionite), are added

to 1 drop of anticoagulated blood on a slide. Cover glass is put on and sealed with petrollium jelly/parraffin wax mixture.

• The reagent is a reducing agent.• In Hb SS, sickling occur immediately, while it may

take 1 hour in Hb S trait.

Page 57: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Hb S solubility Test

• This is done after the Hb electrophoresis to differentiate between some hemoglobins that have the same electrophoretic mobility. (Differentiate Hb D & Hb G from Hb S)

• Only Hb S precipitate in the reduced state when placed in a high molarity phosphate buffer (as it removes oxyegen from test environment).

• 0.05 ml of blood is added to 1 ml of the buffer and mixed in a test tube. Positive results : presence of Hb S : cloudy solution . Negative results : other Hbs : clear solution .

Page 58: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

This is a benign condition, where there is no anaemia and normal appearance of RBC on the BF. Haematuria is the most common symptom. Care must be taken with anesthesia, pregnancy and at high altitude.

Sicle cell trait

Page 59: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders
Page 60: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

THALASSAEMIA

Page 61: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

*There are two alpha genes on each of two chromosome 16 (four genes in the diploid state)

*Only 2 beta globin genes, one on each chromosome 11

**Excess alpha chains are unstable -precipitates in the cell which bind to cell membrane, causing membrane damage

**Excess b chains *High oxygen affinity – poor oxygen transporter

*unstable

Page 62: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Thalassaemias are a heterogeneous group of genetic disorders, which results from a reduced rate of œ (alpha) and ß (beta) chain synthesis.

• In alpha thalassaemia, there is no or little alpha-chain syntheses.

• In beta thalassaemia, there is no or little beta-chain syntheses.

Page 63: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

ALPHA THALASSEMIA

Page 64: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

1- Major alpha- thalassaemia or Hydrops fetalis or Hemoglobin Barts : four genes deletion, leads to complete suppression in the synthesis of alpha-chain. Alpha chain is important in formation of hemoglobin F in neonate, so in this case the formation of this haemoglobin which is important for fetal life will fail, leading to death in uterus.

2- Three genes deletion: leads to moderate to sever microcytic hypochromic anaemia, with splenomegaly. This is known as Hb H disease.

3- Two genes deletion: alpha-thalassaemia trait or minor, associated with mild anaemia.

4-One gene deletion: silent thalassemia usually asymptomatic.

Page 65: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Alpha-Thalassemia minor

*Two alpha genes either on same or opposite chromosomes are missing

*Unaffected globin genes are able to compensate for the affected genes

*Mild anemia – significant microcytosis*Normal lifespan

*Hb. Electrophoresis is normal.

Page 66: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Normal Hemoglobin Electrophoresis

*Hgb F (N = < 1% after age 1 year) *Hgb A2 (N = 2-3.5%)

*Hgb A1 (N=95.5-100%)

Page 67: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Causes: deletion

Type genotype Clinical

0 deletion Normal / --------

One deletion Thal : + heterozygous

-/ Silent carrier: mild hypochromic microcytic

anemia

Two deletions

Thal trait: + homozygous or 0 heterozygous

-/-

/--

Minor: mild hypochromic microcytic anemia

Three deletions

Hb H disease:0/+ double heterozygous

-/-- variable severity, but less severe than Beta Thal Major

deletion of all four a globin genes

Hb Bart’s; - homozygous

--/-- Hydrops Fetalis:In Utero or early neonatal death

complete absence of a globin synthesis

Page 68: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

BETA-THALASSEMIA

Page 69: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Classification:1. ß- Thalassaemia major, very

sever.

2. Intermediate ß- thalassaemia

3. ß- Thalassaemia minor or trait.

Page 70: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

1. Sever anaemia (2-3 g/dl)2. Enlargement of liver and spleen.3. Expansion of bones, leads to Bone

deformities.

Beta-thalassemia Major

Page 71: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Causes: one point mutation

Type genotype Clinical

0 mutation Normal /

Minor point mutation

Minor: Trait0 heterozygousOr+ heterozygous

/0

/+Minimal anemia; no treatment indicated

Two mutations

IntermediaDouble distinct mutation

0/+ severe heterozygoteCan be a spectrum; most often do not require chronic transfusions

Severe gene mutations

Major+ homozygous(double) Or0 homozygous (double)

+/+

0/0

Cooley’s AnemiaHomozygous minor point mutation Need careful observation and intensive treatment

The classification of Beta Thalassemias

Page 72: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

• Laboratory findings:*Hemoglobin as low as 2-3 g/dl

*Markedly microcytic/hypochromic*Marked anisocytosis and poikilocytosis*Basophilic stippling and polychromasia

*Hemoglobin electrophoresis –90% Hb F and increased Hb A2

*HPLC: confirmatory test

Page 73: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

Of moderate severity (Hb 7-10 g/dl). The patient may show bone deformity, enlarged liver and spleen.

Beta-thalassemia intermedia

Page 74: CR Hematology. RBCs Disorders Anemias&Others WBCs Disorders Benign & Malignant Hemostatic Disorders Hematological Disorders

-This is usually symptomless, but mild anaemia may occur.

- Normal iron, ferritin, TIBC- Prenatal counseling.

(25% risk rate if both partners carry beta thalassemia minor).- Hb. Electrophoresis:

4-7 % Hgb A2 92-95% Hgb A1

2-6 % Hgb F